|
|
||||||||
Ann Thorac Surg 1996;61:8-9
© 1996 The Society of Thoracic Surgeons
Department of Medicine and Pathology, Washington University School of Medicine, Barnes Hospital, St. Louis, Missouri
| The first 20% of the full text of this article appears below. |
It has been estimated that 11% of the national red cell resource was used for transfusion support of patients undergoing coronary artery bypass grafting (CABG) in the United States in 1990 [1]. The magnitude of this need, along with the realization that blood safety was compromised by viral agents such as human immunodeficiency virus and hepatitis C virus, has led to studies that have served as descriptive analyses of transfusion outcomes in patients undergoing CABG. For example, determinants of blood use during myocardial revascularization have been identified to include such preoperative factors as female sex, age, preoperative hematocrit level, and preoperative red blood cell mass [2, 3]. Later, a multicenter study of transfusion outcomes in patients undergoing primary, elective CABG demonstrated a marked variability in the transfusion of red cells, plasma, and platelets among institutions, despite apparent homogeneity in these preoperative patient factors that were known to determine blood use [4]. The variability in transfusion outcomes independent of patient factors has been attributed to differences in transfusion triggers, surgical technique, blood conservation strategies, inappropriate transfusions, or a combination of these. What has been lacking, until now, is a validated scoring system that can assess the relevant patient factors, stratify patients at risk for transfusion, and predict
Related Article
Ann. Thorac. Surg. 1996 61: 27-32.
This article has been cited by other articles:
![]() |
H. Reinecke, T. Fetsch, N. Roeder, C. Schmid, A. Winter, M. Ribbing, E. Berendes, M. Block, H. H. Scheld, G. Breithardt, et al. Emergency coronary artery bypass grafting after failed coronary angioplasty: what has changed in a decade? Ann. Thorac. Surg., December 1, 2000; 70(6): 1997 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Hardy, F. Harel, and S. Belisle Transfusions in patients undergoing cardiac surgery with autologous blood Can J Anesth, July 1, 2000; 47(7): 705 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Goodnough, G. J. Despotis, and C. A. Parvin Erythropoietin Therapy in Patients Undergoing Cardiac Operations Ann. Thorac. Surg., December 1, 1997; 64(6): 1579 - 1580. [Full Text] |
||||
![]() |
D. M. Wingerchuk, K. N. Krecke, and J. R. Fulgham Multifocal brain MRI artifacts secondary to embolic metal fragments Neurology, November 1, 1997; 49(5): 1451 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Rosengart, KarlH. Krieger, and J. A. Magovern Predicting Transfusion Ann. Thorac. Surg., December 1, 1996; 62(6): 1885 - 1886. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |